Sudeep Pharma (NSE:SUDEEPPHRM) Quick Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUDEEPPHRM Sudeep Pharma Ltd NSE:SUDEEPPHRM
21 GF Score
Price ₹1,155.00
! 8 Warning Signs
View Full Analysis

What is Sudeep Pharma Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Sudeep Pharma's quick ratio for the quarter that ended in Jun. 2026 was .

Sudeep Pharma has a quick ratio of . It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Sudeep Pharma's Quick Ratio or its related term are showing as below:

NSE:SUDEEPPHRM' s Quick Ratio Range Over the Past 10 Years
Min: 0.93   Med: 1.69   Max: 2.02
Current: 2.02

During the past 5 years, Sudeep Pharma's highest Quick Ratio was 2.02. The lowest was 0.93. And the median was 1.69.

NSE:SUDEEPPHRM's Quick Ratio is ranked better than
65.83% of 998 companies
in the Drug Manufacturers industry
Industry Median: 1.4 vs NSE:SUDEEPPHRM: 2.02

Sudeep Pharma  (NSE:SUDEEPPHRM) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Sudeep Pharma Quick Ratio Related Terms

Sudeep Pharma Quick Ratio Historical Data

* Premium members only.

The historical data trend for Sudeep Pharma's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudeep Pharma Quick Ratio Chart

Sudeep Pharma Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Quick Ratio
0.95 0.84 1.35 1.61 1.96

Sudeep Pharma Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Quick Ratio Get a 7-Day Free Trial - 1.74 - 1.96 -

NSE:SUDEEPPHRM vs ZTS: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sudeep Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sudeep Pharma Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sudeep Pharma's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Sudeep Pharma's Quick Ratio falls into.


NSE:SUDEEPPHRM
21GF Score
Sudeep Pharma Ltd NSE:SUDEEPPHRM
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudeep Pharma Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Sudeep Pharma's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Quick Ratio (A: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(6239.66-2289.49)/2019.625
=1.96

Sudeep Pharma's Quick Ratio for the quarter that ended in Jun. 2026 is calculated as

Quick Ratio (Q: Jun. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-0)/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudeep Pharma Business Description

Other Exchanges 544619:India
Address Gotri-Sevasi Road, 601-602, 6th floor, Sears II, East Wing, Towers - 2, Sevasi, Vadodara, GJ, IND, 391101
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
21GF Score

Get the complete analysis for NSE:SUDEEPPHRM

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,155.00
Price